Optimum spoke to some of Europe’s leading life science VCs to discover what they are looking for from potential investee companies and their top predictions for the next 12 months.

Participants from major investment firms shared their insights on the funding environment for 2025, how to secure funding in a difficult market, and explain why it has never been more important to tell the right story.